CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $332 | -99.9% | 390,000 | -25.3% | 0.52% | -4.0% |
Q3 2022 | $427,000 | -6.4% | 522,009 | +13.5% | 0.55% | +1.3% |
Q2 2022 | $456,000 | -3.4% | 460,103 | +60.0% | 0.54% | -27.5% |
Q1 2022 | $472,000 | +1.5% | 287,500 | +49.0% | 0.74% | +24.4% |
Q4 2021 | $465,000 | -51.0% | 192,909 | -1.7% | 0.60% | -53.2% |
Q3 2021 | $949,000 | +34.6% | 196,168 | -25.7% | 1.28% | +32.0% |
Q2 2021 | $705,000 | -8.1% | 263,975 | +6.0% | 0.97% | +11.8% |
Q1 2021 | $767,000 | +14.0% | 249,006 | +31.7% | 0.87% | -23.7% |
Q4 2020 | $673,000 | +77.6% | 189,081 | +86.8% | 1.14% | +288.1% |
Q2 2019 | $379,000 | -37.3% | 101,218 | -32.6% | 0.29% | -4.6% |
Q1 2019 | $604,000 | +21.8% | 150,199 | +11.2% | 0.31% | -2.8% |
Q4 2018 | $496,000 | +15.3% | 135,123 | +400.5% | 0.32% | +105.2% |
Q3 2017 | $430,000 | – | 27,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
Artal Group S.A. | 500,000 | $425 | 0.02% |
Hikari Power Ltd | 49,959 | $42 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |